Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bookends for Reform

This article was originally published in RPM Report

Executive Summary

The boundaries of the health care reform debate for 2009 are evident in a bipartisan coalition of four senators (two Democrats and two Republicans) who have identified some of the fundamental components of any successful reform effort. Moving the access point for primary care out of the emergency rooms is one of the fundamentals.

You may also be interested in...



Prioritizing Health Care: Reform Gains Early Momentum

Health care reform advocates think the stars are aligned for a major push toward universal coverage under President-elect Barack Obama. They aren’t about to let the free-falling economy get in the way.

CBO's Advisors

The Congressional Budget Office will take on heightened importance in 2009 as health care reform becomes a domestic policy priority. Finding meaningful, scorable savings will be imperative in order to move legislation. With that, CBO’s panel of health advisors, a group of outside health care experts who meet periodically to provide guidance to the agency, will take on an increasingly important role.

Prioritizing Health Care: Reform Gains Early Momentum

Health care reform advocates think the stars are aligned for a major push toward universal coverage under President-elect Barack Obama. They aren’t about to let the free-falling economy get in the way.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel